Search results
1 day ago · The latter accounts for the poor prognosis and high mortality in severe cases of the disease. ... W. et al. Fatal lymphocytic cardiac damage in coronavirus disease 2019 (COVID-19): Autopsy reveals ...
5 days ago · Debunking COVID-19 myths. By Mayo Clinic Staff. Chances are good that you've heard a lot of ways to avoid, treat or cure COVID-19 (coronavirus disease 2019). If what you heard doesn't mention a COVID-19 vaccine or COVID-19 medicine from your healthcare professional, it could be a myth.
4 days ago · COVID-19 is caused by the coronavirus known as SARS-CoV-2. There is no cure for COVID-19, but individuals can be protected against severe illness through vaccination. Learn about the symptoms, treatment, and prevention of COVID-19.
- The Editors of Encyclopaedia Britannica
4 days ago · Causes. Diagnosis. Treatment. Prognosis. Coping. By the end of November 2023, an estimated 87% of the U.S. population had SARS-CoV-2 antibodies indicating they had been infected with COVID-19. Even for those who recover, SARS-CoV-2 poses serious long-term physical and mental challenges.
1 day ago · The SARS-CoV-2 virus is responsible for the human disease known as COVID-19. This virus is capable of generating a spectrum of infections ranging from moderate to severe. Serum apolipoprotein E (ApoE) inhibits inflammation by preserving immune regulatory function.
3 days ago · Purpose Coronavirus disease 2019 (COVID-19) and non-COVID-19 community-acquired pneumonia (NC-CAP) often result in hospitalization with considerable risks of mortality, ICU treatment, and long-term morbidity. A comparative analysis of clinical outcomes in COVID-19 CAP (C-CAP) and NC-CAP may improve clinical management. Methods Using prospectively collected CAPNETZ study data (January 2017 to ...
5 days ago · Background The severity of COVID-19 is influenced by various factors including the presence of respiratory diseases. Studies have indicated a potential relationship between asthma and COVID-19 severity. Objective This study aimed to conduct a genome-wide association study (GWAS) to identify genetic and clinical variants associated with the severity of COVID-19, both among patients with and ...
%20prognosis&ck=FDB75CD5CED776C367FC45A4A855FE3D&idpp=rc&idpview=singleimage&form=rc2idp "coronavirus disease 2019 (covid-19) prognosis1")
%20prognosis&ck=76F526B61DD0EA7845FFEA7609067555&idpp=rc&idpview=singleimage&form=rc2idp "coronavirus disease 2019 (covid-19) prognosis2")
%20prognosis&ck=FDA6662FB6994503C85E10F1368C1018&idpp=rc&idpview=singleimage&form=rc2idp "coronavirus disease 2019 (covid-19) prognosis3")
%20prognosis&ck=A6B1F7183FBDFED78A7D4747A458E525&idpp=rc&idpview=singleimage&form=rc2idp "coronavirus disease 2019 (covid-19) prognosis4")
%20prognosis&ck=454F326F25D4177FE2C45E7285E7E9E0&idpp=rc&idpview=singleimage&form=rc2idp "coronavirus disease 2019 (covid-19) prognosis5")
